Evidence map›Paper›PMID 32899389›Full record

ArticleInternational journal of molecular sciences2020

Comparative Proteomic Analysis Identifies EphA2 as a Specific Cell Surface Marker for Wharton's Jelly-Derived Mesenchymal Stem Cells.

Ashraf Al Madhoun, Sulaiman K Marafie, Dania Haddad, Motasem Melhem, Mohamed Abu-Farha, Hamad Ali, Sardar Sindhu, Maher Atari, Fahd Al-Mulla

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ashraf Al MadhounDepartment of Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-8593-3878
Sulaiman K MarafieDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0002-6786-7296
Dania HaddadDepartment of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Motasem MelhemDepartment of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Mohamed Abu-FarhaDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-8357-1252
Hamad AliDepartment of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-6623-3374
Sardar SindhuDepartment of Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-9936-1575
Maher AtariMedical-Surgical Pathology Department, Regenerative Medicine Research Institute, Universitat Internacional de Catalunya, 08195 Barcelona, Spain.
Fahd Al-MullaDepartment of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-5409-3829
Dasman Diabetes Institute · KWKuwait University · KWUniversitat Internacional de Catalunya · ES

Funding

Kuwait Foundation for the Advancement of Sciences RA-2013-009
6 · The paper itself

Abstract

Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) are a valuable tool in stem cell research due to their high proliferation rate, multi-lineage differentiation potential, and immunotolerance properties. However, fibroblast impurity during WJ-MSCs isolation is unavoidable because of morphological similarities and shared surface markers. Here, a proteomic approach was employed to identify specific proteins differentially expressed by WJ-MSCs in comparison to those by neonatal foreskin and adult skin fibroblasts (NFFs and ASFs, respectively). Mass spectrometry analysis identified 454 proteins with a transmembrane domain. These proteins were then compared across the different cell-lines and categorized based on their cellular localizations, biological processes, and molecular functions. The expression patterns of a selected set of proteins were further confirmed by quantitative reverse transcription polymerase chain reaction (qRT-PCR), Western blotting, and immunofluorescence assays. As anticipated, most of the studied proteins had common expression patterns. However, EphA2, SLC25A4, and SOD2 were predominantly expressed by WJ-MSCs, while CDH2 and Talin2 were specific to NFFs and ASFs, respectively. Here, EphA2 was established as a potential surface-specific marker to distinguish WJ-MSCs from fibroblasts and for prospective use to prepare pure primary cultures of WJ-MSCs. Additionally, CDH2 could be used for a negative-selection isolation/depletion method to remove neonatal fibroblasts contaminating preparations of WJ-MSCs.

Indexed as

BiomarkersCell DifferentiationCell ProliferationCells, CulturedEphrin-A2FibroblastsHumansMesenchymal Stem CellsProteomeReceptor, EphA2SkinWharton JellyBiomarkersEPHA2 protein, humanEphrin-A2ProteomeReceptor, EphA2adult skin fibroblastsmass spectrometryneonate foreskin fibroblastsproteomic analysisWharton’s jelly-derived mesenchymal stem cells

Identifiers

PMID32899389
PMCPMC7503404
OpenAlexW3082104784

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.